Veteran female boxer rips ‘deadly’ USA boxing move allowing transgenders to fight women: ‘There’s just no way’
A female former competitive boxer is slamming one of the sport’s top governing bodies over a decision to allow biological...
Read more
Biden likes his odds in Vegas after a South Carolina landslide as he moves toward likely Trump rematch
President Biden holds a campaign event in Nevada Sunday, two days ahead of the crucial western battleground state’s presidential primary....
Read moreSwing district Democrat with close ties to largest teachers union silent on calls to rescind Biden endorsement
A Democrat representing a swing House district that could prove crucial for both parties in this year’s election is remaining...
Read moreON DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages ON Semiconductor Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important February 12 Deadline in Securities Class Action – ON
NEW YORK, Feb.
Read moreBiden quickly wins South Carolina Democratic presidential primary
South Carolina is once again handing President Biden a ballot box victory. The Associated Press on Saturday projected that the...
Read moreROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Maison Solutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MSS
NEW YORK, Feb.
Read more4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD
51 wet AMD patients with severe disease activity
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages VNET Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VNET
NEW YORK, Feb.
Read moreWashington state diverted $340M in federal COVID funds to immigrants, including via $1,000 checks
A new report is highlighting how federal COVID funds were used in Washington state to give $1,000 checks to illegal...
Read moreEyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
Subgroup analyses underscore favorable clinical p
Read moreADVERTISEMENTS
Shortcodes Ultimate
ADVERTISEMENTS
